ENOV Fair Value Estimate
Blended fair value estimate based on DCF, Graham Number, and earnings-based models.
Enovis Corp
and ESAB Corporation Colfax Corporation is a leading diversified technology company that provides orthopedic and fabrication technology products and services to customers around the world, principally under the DJO and ESAB brands. The Company uses its Colfax Business System, a comprehensive set of tools and processes, to create superior value for customers, shareholders and associates. In March of 2021, Colfax announced its intention to separate into two independent and public companies to accelerate strategic momentum and unlock additional value creation potential. The Company recently announced that it expects to complete the Separation on April 4, 2022 and will then operate under the name Enovis Corporation. Enovis Corporation (NYSE: ENOV) will be an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. ESAB Corporation (NYSE: ESAB) is a world leader in fabrication and specialty gas control technology, providing its partners with advanced equipment, consumables, automation, robotics, and digital solutions which enable the everyday and extraordinary work that shapes our world.
Carries 37.2x more debt than cash on its balance sheet.
Current Price
$23.62
+0.77%GoodMoat Value
$62.36
164.0% undervaluedBlended fair value estimate based on DCF, Graham Number, and earnings-based models.
Graham Number, PEG-based, and Earnings-based models
View Fair Value →Enovis Corp (ENOV) valuation analysis using multiple fair value methodologies. GoodMoat calculates a blended fair value target using discounted cash flow (DCF) analysis, the Graham Number, and earnings-based valuation models.
The GoodMoat Fair Value target for Enovis Corp is $62.36. The current stock price is $23.62, suggesting the stock is 164.0% undervalued.
The price-to-earnings (P/E) ratio is -1.14. Price-to-book ratio is 0.91. Price-to-sales ratio is 0.60. PEG ratio is 0.04.
GoodMoat's valuation models include the Graham Number (based on EPS and book value), an earnings-based model (discounted future EPS), and a PEG-adjusted valuation. The three models are averaged to produce a blended fair value estimate. Use these tools alongside the DCF calculator and reverse DCF to form a comprehensive view of Enovis Corp's intrinsic value.